151 related articles for article (PubMed ID: 12433710)
1. Low-penetrance genes and their involvement in colorectal cancer susceptibility.
de Jong MM; Nolte IM; te Meerman GJ; van der Graaf WT; de Vries EG; Sijmons RH; Hofstra RM; Kleibeuker JH
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1332-52. PubMed ID: 12433710
[TBL] [Abstract][Full Text] [Related]
2. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
[TBL] [Abstract][Full Text] [Related]
3. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
Moore LE; Huang WY; Chatterjee N; Gunter M; Chanock S; Yeager M; Welch B; Pinsky P; Weissfeld J; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1823-7. PubMed ID: 16030123
[TBL] [Abstract][Full Text] [Related]
4. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
[TBL] [Abstract][Full Text] [Related]
5. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
6. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
7. Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma.
Gong Z; Hebert JR; Bostick RM; Deng Z; Hurley TG; Dixon DA; Nitcheva D; Xie D
Cancer; 2007 Mar; 109(5):849-57. PubMed ID: 17236225
[TBL] [Abstract][Full Text] [Related]
8. [A case-control study on the polymorphisms of methylenetetrahydrofolate reductases, drinking interaction and susceptibility in colorectal cancer].
Jiang QT; Chen K; Ma XY; Miao XP; Yao KY; Yu WP; Li LY; Zhu YM; Zhou HG
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):612-6. PubMed ID: 15308044
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
Morita M; Le Marchand L; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Imaizumi N
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):235-41. PubMed ID: 19124503
[TBL] [Abstract][Full Text] [Related]
11. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
13. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
[TBL] [Abstract][Full Text] [Related]
15. GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk.
Tijhuis MJ; Wark PA; Aarts JM; Visker MH; Nagengast FM; Kok FJ; Kampman E
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2943-51. PubMed ID: 16365014
[TBL] [Abstract][Full Text] [Related]
16. An update on the genetics of colorectal cancer.
Kemp Z; Thirlwell C; Sieber O; Silver A; Tomlinson I
Hum Mol Genet; 2004 Oct; 13 Spec No 2():R177-85. PubMed ID: 15358723
[TBL] [Abstract][Full Text] [Related]
17. No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease.
Garcia-Gonzalez MA; Savelkoul PH; Benito R; Santolaria S; Crusius JB; Peña AS; Lanas A
Int J Immunogenet; 2005 Oct; 32(5):299-306. PubMed ID: 16164697
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
19. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study.
Hazra A; Wu K; Kraft P; Fuchs CS; Giovannucci EL; Hunter DJ
Carcinogenesis; 2007 Jul; 28(7):1510-9. PubMed ID: 17389618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
